Diaphragmatic Activity During Weaning With NAVA, a Pilot Study (NAVA: Neurally Adjusted Ventilatory Assist)
NAVA
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
The purpose of this study is to describe the diaphragm electromyographic activity (Edi) in healthy lung patients due to obtain a reference to guide the weaning in those patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2009
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedFirst Submitted
Initial submission to the registry
September 4, 2016
CompletedFirst Posted
Study publicly available on registry
January 23, 2017
CompletedJanuary 23, 2017
January 1, 2017
4 years
September 4, 2016
January 19, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diaphragmatic electromyographic activity description
1 hour
Study Arms (2)
NAVA group with a specific catheter
OTHERThe patients were allocated in the NAVA weaning protocol group
PSV group without a specific catheter
OTHERThe patients were allocated in the PSV (pressure-support ventilation) weaning protocol group
Interventions
The patients were allocated in the NAVA weaning protocol group o in the PSV weaning protocol group
Eligibility Criteria
You may qualify if:
- Patients who were scheduled for elective major surgery in which admission to the CCU (critical care unit) for postoperative care and short-term mechanical ventilation with rapid weaning were anticipated.
You may not qualify if:
- Preoperative altered central nervous system, neuromuscular or lung disease and ASA (american society of anesthesiologists) classification group IV or NYHA (New York heart association) class IV in the case of cardiac patients. At the CCU, before randomisation, we also excluded patients requiring reoperation, and those who exhibited significant postsurgical bleeding, the development of myocardial infarction, and hemodynamic instability.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Mar Garzando Civera, M.D., Ph.D.
Fundación para la investigación del Hospital Clínico Universitario de Valencia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr.
Study Record Dates
First Submitted
September 4, 2016
First Posted
January 23, 2017
Study Start
June 1, 2009
Primary Completion
June 1, 2013
Study Completion
June 1, 2013
Last Updated
January 23, 2017
Record last verified: 2017-01
Data Sharing
- IPD Sharing
- Will share
Shared data will be anonymous